Xian International Medical Stock Current Valuation
| 000516 Stock | 5.69 0.07 1.22% |
Valuation analysis of Xian International helps investors to measure Xian International's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Xian International's Total Cash From Operating Activities is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Financing Activities is expected to grow to about 1.6 B, whereas Cash is forecasted to decline to about 782.4 M. Fundamental drivers impacting Xian International's valuation include:
Price Book 3.5645 | Enterprise Value 16.8 B | Enterprise Value Ebitda 23.7283 | Price Sales 2.6677 | Enterprise Value Revenue 3.4884 |
Overvalued
Today
Please note that Xian International's price fluctuation is relatively risky at this time. Calculation of the real value of Xian International is based on 3 months time horizon. Increasing Xian International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Xian International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xian Stock. However, Xian International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.69 | Real 4.66 | Hype 5.92 |
The real value of Xian Stock, also known as its intrinsic value, is the underlying worth of Xian International Company, which is reflected in its stock price. It is based on Xian International's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Xian International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Xian International Medical helps investors to forecast how Xian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xian International more accurately as focusing exclusively on Xian International's fundamentals will not take into account other important factors: Xian International Medical Company Current Valuation Analysis
Xian International's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Xian International Current Valuation | 16.82 B |
Most of Xian International's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xian International Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Xian International Medical has a Current Valuation of 16.82 B. This is much higher than that of the Broadline Retail sector and significantly higher than that of the Consumer Discretionary industry. The current valuation for all China stocks is notably lower than that of the firm.
Xian Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xian International's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xian International could also be used in its relative valuation, which is a method of valuing Xian International by comparing valuation metrics of similar companies.Xian International is currently under evaluation in current valuation category among its peers.
Xian Fundamentals
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0134 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 16.82 B | ||||
| Shares Outstanding | 2.26 B | ||||
| Shares Owned By Insiders | 34.90 % | ||||
| Shares Owned By Institutions | 3.68 % | ||||
| Price To Book | 3.56 X | ||||
| Price To Sales | 2.67 X | ||||
| Revenue | 4.62 B | ||||
| Gross Profit | (201.57 M) | ||||
| EBITDA | 607 M | ||||
| Net Income | (368.36 M) | ||||
| Total Debt | 4.68 B | ||||
| Book Value Per Share | 1.70 X | ||||
| Cash Flow From Operations | 1.09 B | ||||
| Earnings Per Share | (0.16) X | ||||
| Target Price | 7.2 | ||||
| Number Of Employees | 8.17 K | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 13.02 B | ||||
| Total Asset | 11.32 B | ||||
| Retained Earnings | 274.1 M | ||||
| Working Capital | (2.2 B) | ||||
| Net Asset | 11.32 B |
About Xian International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xian International Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xian International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xian International Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Xian Stock
Xian International financial ratios help investors to determine whether Xian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xian with respect to the benefits of owning Xian International security.